Press Releases

Amniox Medical Announces Publication of Phase 2 Clinical Trial Results Utilizing NEOX® CORD 1K (Trial Code Name: TTAX01) in Wound Repair and Regeneration

Amniox Medical

Data demonstrates 60 percent of wounds achieved complete wound closure, which is compatible with the healing rates observed in previous NEOX Cord 1K retrospective studies. Miami, FL – October 10, 2019 – Miami, FL – October 10, 2019 – Amniox® Medical, Inc. (Amniox), a TissueTechTM, Inc. company and leader in the clinical application of amniotic […]

TissueTech Names New Vice President to Lead Human Resources Operations and Process Improvement Initiatives

TissueTech

Human Birth Tissue Manufacturer is Scaling Up to Transition into a Biologics Provider Miami, FL – October 2, 2019 – TissueTech,TM Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, today announced the appointment of Kim Tripodo to the role of Vice President of Human Resources. In […]

TissueTech Names New Vice President to Oversee Scale Up of Product Lifecycle Management and Technology Transfer Activities

TissueTech

Human Birth Tissue Manufacturer Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 23, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Jerry Chang, PhD to the position of Vice President […]

Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percent

Bio-Tissue

Organization Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 11, 2019 – Bio-Tissue®, Inc., a TissueTech,TM Inc. company, and pioneer and market leader in the development and clinical application of Cryopreserved Amniotic Membrane (CAM) products for ocular surface disease and injury, today announced the expansion […]

TissueTech Appoints New Vice President to Drive Quality Assurance Strategy for all Product Development and Manufacturing Activities

TissueTech

Manufacturer of Human Birth Tissue Products Ramps Up Workflow Processes as it Transitions into a Biologics Provider Miami, FL – September 5, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Sherry Saurini to the position of Vice President of Quality […]

TissueTech Expands its Clinical Program with Medidata’s End-to-end Unified Platform

TissueTech

Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation Unified platform creates a single source of truth for all data, enabling teams to focus on critical oversight activities, site satisfaction and improved patient experiences Miami, Fla. – July 3, 2019 – Medidata announced that TissueTech, Inc.. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform […]

TissueTech Raises $82 million in latest round of equity financing

TissueTech

Miami, Fla. – June 26, 2019 – TissueTech, Inc., the pioneer in regenerative medicine utilizing human umbilical cord and amniotic membrane, today announced the closing of an $82.25 million round of Preferred C equity financing led by EW Healthcare Partners (formerly Essex Woodlands) and followed by the third round of continuous investments from Ballast Point […]

Dr. Mark S. Milner to Present on Cryopreserved Amniotic Membrane at 2019 American Society of Cataract and Refractive Surgery (ASCRS)

Bio-Tissue

Miami, Fla. – May 2, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and the market leader in the clinical application of cryopreserved amniotic membrane-based products for the treatment of diseases and disorders of the ocular surface, today announced that Mark S. Milner, M.D., FACS, Associate Clinical Professor at Yale University Medical School and Co-founder […]

TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

TissueTech

MIAMI – May 14, 2018 – TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent applies to the use of a gel composition comprising morselized placental amniotic membrane and/or morselized umbilical cord. as […]

TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

TissueTech

MIAMI, FL – May 10, 2018 – TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs. “Dr. Young’s appointment continues TissueTech’s tradition as a leader in innovation and quality,” said Amy Tseng, Chief Executive Officer of […]

Archives

  • 2021
  • 2020
  • 2019
  • 2018